Explorer
Serum Institute Of India
News
SII's Covovax Covid Vaccine Now Available For Children In India, Says CEO Adar Poonawalla
Health
NTAGI Approves SII's Covovax Covid-19 Vaccine For Children Between 12-17 Age Group: Report
India
Covovax First Indian COVID Vaccine To Be Sold In Europe, Says SII's Adar Poonawalla
India
Covishield, Covaxin Prices Revised For Private Hospitals Day Before Booster Drive Begins — Check Rates
India
SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
Health
Serum Institute Seeks EUA For Its Covovax Vaccine For 12-17 Years Age Group
India
Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population
India
Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval
News
SII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron
India
CDSCO Panel Recommends Emergency Use Authorisation For SII's Covid vaccine Covovax
Health
Covovax Covid Vaccine Gets WHO Approval, Adar Poonawalla Calls It 'Another Milestone'
Health
Amid Omicron Fear, Expert Committee Gives No Recommendations For COVID Booster Dose: Report
Advertisement
Advertisement
Top Headlines
Cities
Karnataka Power-Sharing Row Heats Up As DK Shivakumar Heads To Delhi: Key Updates
Business
Prime Minister Narendra Modi Calls GDP Growth Q2 'Very Encouraging'
Business
India's GDP Fires Up To 8.2% Despite Tariffs: Here's What The Numbers Say About The Indian Growth Story
World
Vladimir Putin To Visit India On December 4–5 For 23rd Annual India–Russia Summit
